CROI 2014 BOSTON. Hépatites 27LB Combination Oral, Hepatitis C Antiviral Therapy for 6 or 12 Weeks: Final Results of the SYNERGY Trial 60 HCV mono-infectés,
Flow of Patients Through the Trial
CHARM Program: 3 Component trials comparing candesartan with placebo
